login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
KARUNA THERAPEUTICS INC (KRTX) Stock News
NASDAQ:KRTX -
US48576A1007
-
Common Stock
329.83
USD
+0.09 (+0.03%)
Last: 3/15/2024, 8:00:03 PM
329.83
USD
0 (0%)
After Hours:
3/15/2024, 8:00:03 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
KRTX Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Benzinga
- Mentions:
XLK
XLV
BSX
DHR
...
Beyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expect
2 years ago - By: Seeking Alpha
- Mentions:
BMY
MS
Karuna Therapeutics stock drops on no apparent news amid deal with Bristol-Myers Squibb
2 years ago - By: Benzinga
Karuna Therapeutics: Q4 Earnings Insights
2 years ago - By: Seeking Alpha
Karuna Therapeutics GAAP EPS of -$3.01 misses by $0.29 (NASDAQ:KRTX)
2 years ago - By: Karuna Therapeutics, Inc.
Karuna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides General Business Update
2 years ago - By: InvestorPlace
- Mentions:
PSIL
BMY
ACHC
CMPS
Mental Health Mavericks: 3 Stocks Changing the Game
2 years ago - By: Kahn Swick & Foti, LLC
KARUNA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Karuna Therapeutics, Inc. - KRTX
2 years ago - By: Seeking Alpha
- Mentions:
BMY
MRTX
RYZB
Bristol Myers stock cut at Redburn Atlantic (NYSE:BMY)
2 years ago - By: Brodsky & Smith LLC
- Mentions:
CTLT
EVBG
BMY
SLAM
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Catalent, Inc. (NYSE – CTLT), Everbridge, Inc. (Nasdaq – EVBG), Slam Corp. (Nasdaq – SLAM), Karuna Therapeutics, Inc. (Nasdaq – KRTX)
2 years ago - By: Brodsky & Smith LLC
- Mentions:
AVRO
CALB
BCAL
BMY
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AVROBIO, Inc. (Nasdaq – AVRO), California BanCorp (Nasdaq – CALB), Exro Technologies Inc. (OTC – EXROF), Karuna Therapeutics, Inc. (Nasdaq – KRTX)
2 years ago - By: Seeking Alpha
- Mentions:
BMY
LLY
BIIB
Karuna’s KarXT is Evaluate's most anticipated drug for 2024
2 years ago - By: Seeking Alpha
- Mentions:
BMY
LLY
BIIB
Karuna’s KarXT tops Evaluate’s most anticipated drug list (NYSE:BMY)
2 years ago - By: Brodsky & Smith LLC
- Mentions:
TAST
ANSS
HMST
BMY
...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Karuna Therapeutics, Inc. (Nasdaq – KRTX), Carrols Restaurant Group, Inc. (Nasdaq - TAST), Ansys, Inc. (Nasdaq - ANSS), HomeStreet, Inc. (Nasdaq - HMST)
2 years ago - By: Seeking Alpha
- Mentions:
BMY
Bristol-Myers almost lost Karuna buyout to third party (NYSE:BMY)
2 years ago - By: Brodsky & Smith LLC
- Mentions:
TAST
ANSS
HMST
BMY
...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Karuna Therapeutics, Inc. (Nasdaq – KRTX), Carrols Restaurant Group, Inc. (Nasdaq - TAST), Ansys, Inc. (Nasdaq - ANSS), HomeStreet, Inc. (Nasdaq - HMST)
2 years ago - By: Seeking Alpha
- Mentions:
BMY
JPM
MRTX
RYZB
Bristol-Myers looking for smaller deals after 2023 shopping spree: report (NYSE:BMY)
2 years ago - By: Investor's Business Daily
- Mentions:
LLY
ARWR
XBI
BMY
...
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
2 years ago - By: Brodsky & Smith LLC
- Mentions:
RYZB
GRCL
DSKE
BMY
...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX)
2 years ago - By: Seeking Alpha
- Mentions:
BMY
BAC
MRTX
RYZB
Bristol-Myers Squibb stock cut to Neutral at BofA (NYSE:BMY)
2 years ago - By: Seeking Alpha
- Mentions:
BMY
ABBV
PFE
IMGN
...
What's in store for biotech M&A and IPOs in 2024? (NYSE:BMY)
2 years ago - By: Kahn Swick & Foti, LLC
KARUNA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Karuna Therapeutics, Inc. - KRTX
2 years ago - By: Investor's Business Daily
- Mentions:
TSLA
BMY
LI
NIO
...
Stock Market Ending 2023 On High Note; Tesla, Drug M&A In Focus: Weekly Review
2 years ago - By: Brodsky & Smith LLC
- Mentions:
BMY
RYZB
GRCL
DSKE
...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX)
Please enable JavaScript to continue using this application.